載入...
An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease
Background: GFF MDI is a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler formulated using co-suspension delivery technology. This open-label, single-arm multicenter study (NCT02268396) evaluated the accuracy, reliability, and functionality of the GFF MDI AeroCount(®) d...
Na minha lista:
| 發表在: | J Aerosol Med Pulm Drug Deliv |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Mary Ann Liebert, Inc., publishers
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354605/ https://ncbi.nlm.nih.gov/pubmed/30335559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jamp.2018.1466 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|